Canadian Pharma Co.'s Units File $61M Ch. 15 In Delaware
Citing $61.5 million in total liabilities and a looming liquidity crisis, the American arm of Ontario-based Acerus Pharmaceuticals Corp. filed a Chapter 15 bankruptcy petition in Delaware on Sunday in connection...To view the full article, register now.
Already a subscriber? Click here to view full article